Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia

Clinical trial NCT00142155 · COMPLETED

Trial details

NCT number: NCT00142155
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Waldenstrom's Macroglobulinemia

Start date: 2002-01-01
Primary completion: 2007-03-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.